Open Beta
MetriLume

US marketsOPRX

SEC-sourced researchBeta

OPRX

OptimizeRx Corp

Company comparison ↗

Data passport

CIK
0001448431
Exchange
Nasdaq
Business activity
— · SIC 7389
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 92,127,000.0000 USD; December 2025: 109,429,000.0000 USD109.4M USD0 USD0December 2024December 2025
OPRX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202492,127,000.0000Mar 12, 2026
December 2025109,429,000.0000Mar 12, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025109,429,000.00005,132,000.000018,715,000.0000176,918,000.000048,624,000.0000Mar 12, 2026
December 202492,127,000.0000-20,110,000.00004,889,000.0000171,168,000.000054,170,000.0000Mar 12, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$109.43MDecember 2025Mar 12, 202610-K
Previous period revenueRevenues$92.13MDecember 2024Mar 12, 202610-K
Net incomeNetIncomeLoss$5.13MDecember 2025Mar 12, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$18.72MDecember 2025Mar 12, 202610-K
Total assetsAssets$176.92MDecember 2025Mar 12, 202610-K
Total liabilitiesLiabilities$48.62MDecember 2025Mar 12, 202610-K

New filings

Explore methodology ↗